ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000260742.1	Gefitinib	Esophageal cancer	0.019595582	Resistant
ENSG00000260742.1	Gefitinib	Sarcoma	0.016465218	Resistant
ENSG00000260742.1	Gefitinib	Breast invasive carcinoma	0.026693882	Sensitive